IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Atopic dermatitis (AD) is a common inflammatory skin disease characterized by itching and lesions.
• Staphylococcus aureus colonization is linked to AD severity, but its precise role is unclear.

Purpose of the Study:

• To investigate the role of keratinocyte immune responses in atopic dermatitis development.
• To identify novel therapeutic targets for atopic dermatitis.

Main Methods:

• Single-cell RNA sequencing to analyze keratinocyte responses to Staphylococcus aureus.
• In vivo studies using animal models of atopic dermatitis.
• Genetic manipulation to assess the function of IL-24 and its receptor.

Main Results:

• Keratinocytes induce Interleukin-24 (IL-24) when exposed to methicillin-resistant S. aureus (MRSA).
• Administering IL-24 protein worsened AD-like symptoms in animal models.
• Deleting Il24 or its receptor Il20rb in keratinocytes reduced allergic inflammation.
• IL-24 promotes AD by increasing IL-33 production, enhancing type 2 immunity.

Conclusions:

• IL-24 is a key mediator in the onset and progression of atopic dermatitis.
• IL-24 represents a promising therapeutic target for managing AD and the atopic march.